A detailed history of Rtw Investments, LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Rtw Investments, LP holds 3,557,347 shares of URGN stock, worth $43.5 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
3,557,347
Previous 3,257,347 9.21%
Holding current value
$43.5 Million
Previous $48.9 Million 22.17%
% of portfolio
1.0%
Previous 0.78%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.72 - $19.2 $3.82 Million - $5.76 Million
300,000 Added 9.21%
3,557,347 $59.7 Million
Q1 2024

May 15, 2024

BUY
$13.81 - $19.33 $21.1 Million - $29.6 Million
1,530,539 Added 88.63%
3,257,347 $48.9 Million
Q4 2023

Feb 14, 2024

BUY
$10.87 - $15.93 $9.45 Million - $13.8 Million
869,344 Added 101.39%
1,726,808 $25.9 Million
Q3 2021

Nov 15, 2021

BUY
$14.31 - $18.39 $12.3 Million - $15.8 Million
857,464 New
857,464 $14.4 Million

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $278M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.